Astra S DR MRI IPG (X3DR01); Astra S SR MRI IPG (X3SR01); Astra XT DR MRI IPG (X1DR01); Astra XT SR MRI IPG (X1SR01); Az
Medtronic, Inc. · Decision date Oct 23, 2026
What did the FDA decide?
FDA recorded a 30-Day Notice decision (OK30) dated 2026-10-23 for PMA supplement P980035/S848 from Medtronic, Inc., covering Astra S DR MRI IPG (X3DR01), Astra S SR MRI IPG (X3SR01), Astra XT DR MRI IPG (X1DR01), Astra XT SR MRI IPG (X1SR01) and additional Astra models named in the truncated title. The device category is permanent implantable pulse generator, cardiovascular specialty, product code NVZ.
The recorded scope is a manufacturing process change: introduction of a second Medium Rate (MR) Headers manufacturing line and inspection updates to the MR Headers Line currently in production, filed under Process Change - Manufacturer/Sterilizer/Packager/Supplier. This supplement concerns header production, not a new approval of the full generator system. The source lists no supporting documents, so inspection methods, line qualification data and any effect on finished-device specifications remain unknown.
The OK30 code and the absence of linked documents leave the basis for the decision unstated here; no clinical, performance or labeling conclusions follow from this record.
FDA approval order statement
the introduction of a second Medium Rate (MR) Headers manufacturing line and to make inspection updates to the MR Headers Line that is currently in production
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 23, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P980035/S848
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- NVZ
- Decision code
- OK30
- Decision date
- Oct 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pulse generator, permanent, implantable.
- Applicant
- Medtronic, Inc.
- Product code
- NVZ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P980035. Subsequent supplements may change the device or its indications.
FDA decision timeline
P980035 · Original PMA
MEDTRONIC KAPPA 700/600 SERIES PULSE GENERATORS AND MODEL 9953 SOFTWARE
P980035/S848 received
Application receipt date recorded by FDA.
P980035/S847 · Related supplement
Astra S DR MRI IPG, Astra S SR MRI IPG, Astra XT SR MRI IPG, Azure S DR MRI IPG, Azure S SR MRI IPG, Azure XT DR MRI IPG
P980035/S848 · FDA decision
30-Day Notice
P980035/S849 · Related supplement
Astra S DR MRI IPG; Astra S SR MRI IPG; Astra XT DR MRI IPG; Astra XT SR MRI IPG; Azure S DR MRI IPG; Azure S SR MRI IPG
Timeline entries are records held by MedtechLedger for P980035. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P980035
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA approval | Jan 29, 1999 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 5, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P980035/S848
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

